GlaxoSmithKline CEO Andrew Witty set a precedent back in 2009, when his company placed several patents in a public pool to help developing countries find cures for HIV and other diseases–and then challenged other companies to do the same.
written on 02.04.2014
ViiV adds pricey new HIV drug Tivicay to patent pool
